Work

Can neuromodulation alleviate cognitive deficits?

Year: 2024

Type: article

Abstract: Since the Food and Drug Administration (FDA) approved Transcranial Magnetic Stimulation (TMS) for depression as a non-invasive brain stimulation approach in 2008, its application has revolutionized psychiatry. Recently, new indications such as Obsessive Compulsive Disorder (OCD), smoking cessation, and anxiety with comorbid Major Depressive Disorder (MDD) have been approved. Additionally, various methodological options have exponentially increased and significantly diverged across studies. Factors such as location, waveform, energy or generated electric field (EF), direction of the EF, frequency of sessions, total number of stimulations during treatment, and timing can all be varied even for the same indication.

Source: International Psychogeriatrics

DOI: 10.1016/j.inpsyc.2024.100021

Authors: Miklos Argyelan, Sohag Sanghani

Institutions: Feinstein Institute for Medical Research, Zucker Hillside Hospital, Hofstra University, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell

Language: English

Topic: Transcranial Magnetic Stimulation Studies

Subfield: Neurology

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,450